These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 31140425)
1. [Expression of NUF2 in breast cancer and its clinical significance]. Sun J; Chen J; Wang Z; Deng Y; Liu L; Liu X Nan Fang Yi Ke Da Xue Xue Bao; 2019 May; 39(5):591-597. PubMed ID: 31140425 [TBL] [Abstract][Full Text] [Related]
2. [BUB1 gene is highly expressed in gastric cancer:analysis based on Oncomine database and bioinformatics]. Li X; He J; Yu M; Zhang W; Sun J Nan Fang Yi Ke Da Xue Xue Bao; 2020 May; 40(5):683-692. PubMed ID: 32897212 [TBL] [Abstract][Full Text] [Related]
3. Screening of differentially expressed genes and identification of NUF2 as a prognostic marker in breast cancer. Xu W; Wang Y; Wang Y; Lv S; Xu X; Dong X Int J Mol Med; 2019 Aug; 44(2):390-404. PubMed ID: 31198978 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance and prospective molecular mechanism of NUF2 in gastric cancer exploration: A comprehensive study based on the GeneChip, GEO, Oncomine, and TCGA databases. Ge L; Sun Q; Xia L; Xu X Medicine (Baltimore); 2022 Jul; 101(26):e29802. PubMed ID: 35777029 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of the expression, prognostic significance, and regulation pathway of G2E3 in breast cancer. Shen Y; Xue J; Yu J; Jiang Y; Bu J; Zhu T; Gu X; Zhu X World J Surg Oncol; 2022 Dec; 20(1):398. PubMed ID: 36517818 [TBL] [Abstract][Full Text] [Related]
6. NUF2 Promotes Breast Cancer Development as a New Tumor Stem Cell Indicator. Deng Y; Li J; Zhang Y; Hu H; Wan F; Min H; Zhou H; Gu L; Liao X; Zhou J; Zhou J Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835637 [TBL] [Abstract][Full Text] [Related]
7. NUF2 as an anticancer therapeutic target and prognostic factor in breast cancer. Lv S; Xu W; Zhang Y; Zhang J; Dong X Int J Oncol; 2020 Dec; 57(6):1358-1367. PubMed ID: 33173994 [TBL] [Abstract][Full Text] [Related]
8. Integrative Multi-Omics Analysis of Identified NUF2 as a Candidate Oncogene Correlates With Poor Prognosis and Immune Infiltration in Non-Small Cell Lung Cancer. Chen M; Li S; Liang Y; Zhang Y; Luo D; Wang W Front Oncol; 2021; 11():656509. PubMed ID: 34178642 [TBL] [Abstract][Full Text] [Related]
9. Jiang F; Huang X; Yang X; Zhou H; Wang Y Front Oncol; 2022; 12():795971. PubMed ID: 35814368 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of the expression, prognostic significance, and function of FAM83 family members in breast cancer. Jin Y; Yu J; Jiang Y; Bu J; Zhu T; Gu X; Zhu X World J Surg Oncol; 2022 Jun; 20(1):172. PubMed ID: 35650627 [TBL] [Abstract][Full Text] [Related]
11. Expression and clinical significance of NUF2 in kidney renal clear cell carcinoma. Shan L; Zhu XL; Zhang Y; Gu GJ; Cheng X Transl Androl Urol; 2021 Sep; 10(9):3628-3637. PubMed ID: 34733658 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of NUF2 inhibits tumor growth and induces apoptosis by regulating lncRNA AF339813. Hu P; Shangguan J; Zhang L Int J Clin Exp Pathol; 2015; 8(3):2638-48. PubMed ID: 26045769 [TBL] [Abstract][Full Text] [Related]
13. Identification of NUF2 and FAM83D as potential biomarkers in triple-negative breast cancer. Zhai X; Yang Z; Liu X; Dong Z; Zhou D PeerJ; 2020; 8():e9975. PubMed ID: 33005492 [TBL] [Abstract][Full Text] [Related]
14. [Analysis of the correlation between the expression of WFDC2 in B cells of lung adenocarcinoma tissue and the survival rate of patients]. Zhang H; Lu J; Yang Y; Wang L Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 May; 35(5):425-433. PubMed ID: 31223112 [TBL] [Abstract][Full Text] [Related]
15. Biological and Clinical Significance of MAD2L1 and BUB1, Genes Frequently Appearing in Expression Signatures for Breast Cancer Prognosis. Wang Z; Katsaros D; Shen Y; Fu Y; Canuto EM; Benedetto C; Lu L; Chu WM; Risch HA; Yu H PLoS One; 2015; 10(8):e0136246. PubMed ID: 26287798 [TBL] [Abstract][Full Text] [Related]
16. Xie X; Jiang S; Li X Front Oncol; 2021; 11():621373. PubMed ID: 33767990 [No Abstract] [Full Text] [Related]
17. BUB1 as a novel marker for predicting the immunotherapy efficacy and prognosis of breast cancer. Zhou R; Liu M; Li M; Peng Y; Zhang X Transl Cancer Res; 2024 Sep; 13(9):4534-4554. PubMed ID: 39430818 [TBL] [Abstract][Full Text] [Related]
18. ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC. Griffin NI; Sharma G; Zhao X; Mirza S; Srivastava S; Dave BJ; Aleskandarany M; Rakha E; Mohibi S; Band H; Band V Breast Cancer Res; 2016 Nov; 18(1):113. PubMed ID: 27852327 [TBL] [Abstract][Full Text] [Related]
19. Targeting TPX2 suppresses proliferation and promotes apoptosis via repression of the PI3k/AKT/P21 signaling pathway and activation of p53 pathway in breast cancer. Chen M; Zhang H; Zhang G; Zhong A; Ma Q; Kai J; Tong Y; Xie S; Wang Y; Zheng H; Guo L; Lu R Biochem Biophys Res Commun; 2018 Dec; 507(1-4):74-82. PubMed ID: 30454896 [TBL] [Abstract][Full Text] [Related]
20. [Screening of cell cycle-related genes regulated by KIAA0101 in gastric cancer]. Wang Z; Dang C; Yan R; Zhang H; Yuan D; Li K Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1151-1158. PubMed ID: 30377125 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]